BINEX Co., Ltd. (KOSDAQ:053030)
South Korea · Delayed Price · Currency is KRW 6,370.00
-190.00 (-2.90%)
Jul 21, 2026, 3:30 PM KST
BINEX Market Cap
BINEX has a market cap or net worth of 208.92 billion as of July 20, 2026. Its market cap has decreased by -62.96% in one year.
Market Cap
208.92B
Enterprise Value
292.52B
Revenue
164.00B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,370.00
ChartMarket Cap Chart
Since March 1, 2002, BINEX's market cap has increased from 25.29B to 208.92B, an increase of 726.23%. That is a compound annual growth rate of 9.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 208.92B | -56.21% |
| Dec 30, 2025 | 477.08B | -18.32% |
| Dec 30, 2024 | 584.09B | 111.03% |
| Dec 28, 2023 | 276.77B | -22.51% |
| Dec 29, 2022 | 357.18B | -24.01% |
| Dec 30, 2021 | 470.05B | -43.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genomictree | 289.66B |
| SillaJen | 286.81B |
| Proteina | 265.95B |
| EASY BIO,Inc. | 208.09B |
| GC Cell | 200.46B |
| Anterogen.Co.,Ltd. | 183.21B |
| HLB Therapeutics | 171.62B |
| JETEMA, | 165.93B |